Effectiveness and toxicities of cetuximab in combination with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis

被引：0
|
作者：
Wu, L-R. [1 ]
Xu, J-H. [1 ]
Guo, W-J. [1 ]
He, X. [1 ]
机构：
[1] Nanjing Med Univ Affiliated Canc Hosp, Dept Radiat Oncol, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1072P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis
    Wu, Li-Rong
    Zhu, Huan-feng
    Xu, Jianhua
    Jiang, Xue-song
    Yin, Li
    Jiang, Ning
    Zong, Dan
    Wang, Fei-jiang
    Huang, Sheng-fu
    Bian, Xiu-hua
    Wu, Jian-feng
    Song, Dan
    Guo, Wen-jie
    Liu, Ju-Ying
    He, Xia
    JOURNAL OF CANCER, 2018, 9 (09): : 1642 - 1650
  • [2] Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis
    Tang, Si-Qi
    Xu, Cheng
    Wang, Xiao-Shuai
    Tang, Ling-Long
    Li, Wen-Fei
    Chen, Lei
    Mao, Yan-Ping
    Guo, Rui
    Liu, Qing
    Sun, Ying
    Ma, Jun
    ORAL ONCOLOGY, 2020, 105
  • [3] Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
    Liao, Jun-Fang
    Zhang, Qun
    Du, Xiao-Jing
    Lan, Mei
    Liu, Shan
    Xia, Yun-Fei
    Cai, Xiu-Yu
    Luo, Wei
    CANCER COMMUNICATIONS, 2019, 39
  • [4] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Feng, Hui-Xia
    Guo, Su-Ping
    Li, Gui-Rong
    Zhong, Wen-Huan
    Chen, Liu
    Huang, Li-Ru
    Qin, Hui-Ying
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [5] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Hui-Xia Feng
    Su-Ping Guo
    Gui-Rong Li
    Wen-Huan Zhong
    Liu Chen
    Li-Ru Huang
    Hui-Ying Qin
    Medical Oncology, 2014, 31
  • [6] Weekly docetaxel concurrent chemoradiotherapy versus cisplatin in locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis
    Liao, J. F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis
    Gu, Benxing
    Qian, Liwen
    Yu, Hong
    Hu, Jianbin
    Wang, Qi
    Shan, Jingjing
    Shi, Liming
    Liu, Hai
    Yang, Qichu
    Liang, Xiao
    Cai, Xiujun
    Sun, Xiaonan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 138 - 145
  • [8] Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
    Zhu, Ying
    Xue, Fen
    BMC CANCER, 2024, 24 (01)
  • [9] Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis (vol 39, 40, 2019)
    Liao, Jun-Fang
    Zhang, Qun
    Du, Xiao-Jing
    Lan, Mei
    Liu, Shan
    Xia, Yun-Fei
    Cai, Xiu-Yu
    Luo, Wei
    CANCER COMMUNICATIONS, 2019, 39 (01):
  • [10] Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis
    Xia, Wei-Xiong
    Liang, Hu
    Lv, Xing
    Wang, Lin
    Qian, Chao-Nan
    Ye, Yan-Fang
    Ke, Liang-Ru
    Qiu, Wen-Ze
    Yu, Ya-Hui
    Huang, Xin-Jun
    Liu, Guo-Ying
    Zhao, Chong
    Xiang, Yan-Qun
    Guo, Xiang
    ORAL ONCOLOGY, 2017, 67 : 167 - 174
12345